Filtros : "Emirados Árabes Unidos" "2010" Removidos: "TRABALHO DE EVENTO-RESUMO" "Journal of forensic and legal medicine" "ICB-BMB" "ADMINISTRACAO" "México" "Cuba" "Israel" Limpar

Filtros



Refine with date range


  • Source: Current Protein and Peptide Science. Unidade: FCF

    Subjects: AMINOÁCIDOS, PEPTÍDEOS, MACROMOLÉCULA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VARCA, Gustavo Henrique Costa et al. Cyclodextrins: An overview of the complexation of pharmaceutical proteins. Current Protein and Peptide Science, v. 11, n. 4, p. 255-263, 2010Tradução . . Disponível em: https://doi.org/10.2174/138920310791233387. Acesso em: 01 ago. 2024.
    • APA

      Varca, G. H. C., Andréo Filho, N., Lopes, P. S., & Ferraz, H. G. (2010). Cyclodextrins: An overview of the complexation of pharmaceutical proteins. Current Protein and Peptide Science, 11( 4), 255-263. doi:10.2174/138920310791233387
    • NLM

      Varca GHC, Andréo Filho N, Lopes PS, Ferraz HG. Cyclodextrins: An overview of the complexation of pharmaceutical proteins [Internet]. Current Protein and Peptide Science. 2010 ; 11( 4): 255-263.[citado 2024 ago. 01 ] Available from: https://doi.org/10.2174/138920310791233387
    • Vancouver

      Varca GHC, Andréo Filho N, Lopes PS, Ferraz HG. Cyclodextrins: An overview of the complexation of pharmaceutical proteins [Internet]. Current Protein and Peptide Science. 2010 ; 11( 4): 255-263.[citado 2024 ago. 01 ] Available from: https://doi.org/10.2174/138920310791233387
  • Source: Current Medicinal Chemistry. Unidades: FFCLRP, IQSC

    Subjects: QUÍMICA INORGÂNICA, RUTÊNIO

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TFOUNI, Elia et al. Tailoring NO donors metallopharmaceuticals: ruthenium nitrosyl ammines and aliphatic teraazamacrocycles. Current Medicinal Chemistry, v. 17, p. 3643-3657, 2010Tradução . . Acesso em: 01 ago. 2024.
    • APA

      Tfouni, E., Doro, F. G., Figueiredo, L. E., Pereira, J. C. M., Metzker, G., & Franco, D. W. (2010). Tailoring NO donors metallopharmaceuticals: ruthenium nitrosyl ammines and aliphatic teraazamacrocycles. Current Medicinal Chemistry, 17, 3643-3657.
    • NLM

      Tfouni E, Doro FG, Figueiredo LE, Pereira JCM, Metzker G, Franco DW. Tailoring NO donors metallopharmaceuticals: ruthenium nitrosyl ammines and aliphatic teraazamacrocycles. Current Medicinal Chemistry. 2010 ; 17 3643-3657.[citado 2024 ago. 01 ]
    • Vancouver

      Tfouni E, Doro FG, Figueiredo LE, Pereira JCM, Metzker G, Franco DW. Tailoring NO donors metallopharmaceuticals: ruthenium nitrosyl ammines and aliphatic teraazamacrocycles. Current Medicinal Chemistry. 2010 ; 17 3643-3657.[citado 2024 ago. 01 ]
  • Source: Letters in Drug Design & Discovery. Unidade: FCF

    Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, PROTEINASES, MODELAGEM MOLECULAR

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TROSSINI, Gustavo Henrique Goulart et al. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs. Letters in Drug Design & Discovery, v. 7, n. 7, p. 528-533, 2010Tradução . . Disponível em: https://doi.org/10.2174/157018010791526287. Acesso em: 01 ago. 2024.
    • APA

      Trossini, G. H. G., Chin, C. M., Menezes, C. M. de S., & Ferreira, E. I. (2010). Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs. Letters in Drug Design & Discovery, 7( 7), 528-533. doi:10.2174/157018010791526287
    • NLM

      Trossini GHG, Chin CM, Menezes CM de S, Ferreira EI. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 7): 528-533.[citado 2024 ago. 01 ] Available from: https://doi.org/10.2174/157018010791526287
    • Vancouver

      Trossini GHG, Chin CM, Menezes CM de S, Ferreira EI. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 7): 528-533.[citado 2024 ago. 01 ] Available from: https://doi.org/10.2174/157018010791526287
  • Source: Letters in Drug Design & Discovery. Unidades: IQ, FCF

    Subjects: QUÍMICA VERDE, ANTIOXIDANTES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, F. A. N et al. Antioxidant capacity of 2-(3,5-diaryl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazoles. Letters in Drug Design & Discovery, v. 7, n. 9, p. 657-660, 2010Tradução . . Disponível em: https://doi.org/10.2174/157018010792929513. Acesso em: 01 ago. 2024.
    • APA

      Silva, F. A. N., Pizzuti, L., Quina, F. H., Souza Junior, S. P. de, Rosales, P. F., Siqueira, G. M., et al. (2010). Antioxidant capacity of 2-(3,5-diaryl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazoles. Letters in Drug Design & Discovery, 7( 9), 657-660. doi:10.2174/157018010792929513
    • NLM

      Silva FAN, Pizzuti L, Quina FH, Souza Junior SP de, Rosales PF, Siqueira GM, Pereira CMP de, Barros SB de M, Rivelli DP. Antioxidant capacity of 2-(3,5-diaryl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazoles [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 9): 657-660.[citado 2024 ago. 01 ] Available from: https://doi.org/10.2174/157018010792929513
    • Vancouver

      Silva FAN, Pizzuti L, Quina FH, Souza Junior SP de, Rosales PF, Siqueira GM, Pereira CMP de, Barros SB de M, Rivelli DP. Antioxidant capacity of 2-(3,5-diaryl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazoles [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 9): 657-660.[citado 2024 ago. 01 ] Available from: https://doi.org/10.2174/157018010792929513

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024